S

Suven Pharmaceuticals Ltd

Pharmaceuticals

MIDCAP

Pharmaceuticals

Live Performance vs 

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 2 analysts offering recommendations for Suven Pharmaceuticals Ltd

50%

Buy

0%

Hold

50%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio110.7050.94
PB Ratio16.216.51
Dividend Yield0.52%

Understand what these metrics mean. 

About the company

S

Suven Pharmaceuticals Ltd

Suven Pharmaceuticals is engaged in Contract Research and Manufacturing Services (CRAMS), Drug Discovery & Development Support Services (DDDSS), Drug Discovery & Research/Clinical Pipeline, and Formulation Development

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions